29.10.2007
opracowanie na podstawie: Once-yearly zoledronic acid for treatment of postmenopausal osteoporosis
D.M. Black, P.D. Delmas, R. Eastell, I.R. Reid, S. Boonen, J.A. Cauley, F. Cosman, P. Lakatos, P.C. Leung, Z. Man, C. Mautalen, P. Mesenbrink, H. Hu, J. Caminis, K. Tong, T. Rosario-Jansen, J. Krasnow, T.F. Hue, D. Sellmeyer, E.F. Eriksen, S.R. Cummings, for the HORIZON Pivotal Fracture Trial
The New England Journal of Medicine, 2007; 356: 1809–1822